silico drug repurposing
precision of drug REPurpOsing TRIALs
silico trials
silico approach
silico-based approach
drug repositionings
high precision clinical trials
related disease phenotypes
efficacy
defined disease phenotypes
drug development costs
mechanism-based patient cohort
predominant cerebro-cardiovascular phenotypes
virtual patient cohort
clinical validation
risks
programme
rapid patient benefit
current disease definitions
shortest time
time-frame
animal numbers
animal experimentation
preclinical systematic reviews
preclinical randomised confirmatory trial
concept
pRCTs
patients
meta-analyses
symptom
disturbance of self-regulation equilibria of biomolecular processes
models
open access
size
result
exclusive mechanistic biomarker panel
biomedical product classes
drugs
diagnostics
organ
diseases
translation
systems medicine
novo
apparent phenotype
computer simulation parameters
platform
pendant
vagueness
duration
industrial competitiveness
uncertainty